Genprex must keep Nasdaq bid price at or above $1 through Dec. 7 to retain listing
GNPX•Nasdaq compliance deadline
Genprex must keep its Nasdaq bid price at or above $1 through Dec. 7 to retain listing.
- Genprex regained Nasdaq compliance with the $1 minimum bid price rule, following a Nasdaq Hearings Panel determination on Aug. 4, 2026.
- The panel will keep jurisdiction until Dec. 7, 2026, requiring the stock to close at or above $1 each trading day.
- Any new Nasdaq listing rule deficiency before Dec. 7 triggers a seven-day deadline to submit a cure plan, risking delisting.
